SETD2-mutant ccRCC cells fail to activate p53 by phosphorylation and increased protein level which is critical as a master guardian of the genome after DNA damage, showing disturbed cell-cycle checkpoint activation and reduced cell survival [76]. This evidence concerns the gene TP53 and nonpapillary renal cell carcinoma.